Blockchain Registration Transaction Record

Nutriband CEO Featured in Opioid Crisis Documentary

Nutriband CEO Gareth Sheridan discusses the opioid crisis and AVERSA abuse-deterrent tech in a new documentary. Learn how NTRB is innovating safer transdermal patches.

This news matters because the opioid crisis continues to devastate communities across the United States, with abuse and accidental exposure to high-risk medications like fentanyl claiming thousands of lives annually. Nutriband's AVERSA™ abuse-deterrent technology represents a potential breakthrough in preventing the misuse and diversion of transdermal patches, which are particularly vulnerable to abuse due to their concentrated drug content. By participating in this documentary, CEO Gareth Sheridan brings attention to innovative pharmaceutical solutions that could help mitigate the crisis while ensuring that patients with legitimate medical needs retain access to essential pain therapies. As the company advances its lead product—an abuse-deterrent fentanyl patch—investors and healthcare stakeholders should monitor its progress, as successful commercialization could significantly impact public health and set a new standard for safer transdermal drug delivery.